KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 248 filers reported holding KARUNA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,672,600 | +36.5% | 140,000 | +75.0% | 1.38% | +42.1% |
| Q2 2023 | $17,348,000 | +119286.1% | 80,000 | 0.0% | 0.97% | +1.6% |
| Q1 2023 | $14,531 | -32.8% | 80,000 | -27.3% | 0.96% | -33.8% |
| Q4 2022 | $21,615 | -99.9% | 110,000 | -26.7% | 1.45% | -38.7% |
| Q3 2022 | $33,740,000 | +113.4% | 150,000 | +20.0% | 2.36% | +97.2% |
| Q2 2022 | $15,814,000 | -16.8% | 125,000 | -16.7% | 1.20% | -18.1% |
| Q1 2022 | $19,018,000 | – | 150,000 | – | 1.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
| Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
| Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
| Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
| First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
| Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
| Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
| Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
| DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |